Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04230421Recruiting
Smartphone treatment program for bipolar disorder
This trial is testing a smartphone-based treatment approach for people living with bipolar disorder. It may help by delivering support and care tools in a way that’s easier to use day to day.
CopenhagenAges 18 years+ - NCT04230785Recruiting
Blood RNA test during clot-busting treatment for stroke
This trial studies special molecules in the blood (non-coding RNA) in people having an acute ischemic stroke treated with a procedure to remove clots. It may help doctors better understand how the body responds and potentially improve future stroke care.
Nanjing, JiangsuAges 18–90 - NCT04231006Recruiting
High-dose salvage radiation for prostate cancer that came back locally
This trial studies high-dose radiation (HDR) given after prostate cancer returns only in the prostate/seminal vesicles. It may help by trying to control the cancer when it has not spread elsewhere, using targeted treatment based on MRI and biopsy proof.
Aarhus, Region MidtAges 18 years+ - NCT04230616Recruiting
Testing a knee device to ease osteoarthritis pain
This study tests how well and how safely a knee treatment works for adults with painful knee osteoarthritis seen on X-ray. You might join if you need meaningful pain relief and help with daily function, and can complete required scans and study instructions.
Sint-Truiden, LimburgAges 18 years+ - NCT04234022Recruiting
Test a drug approach for multiple myeloma and leukemia
This trial studies a treatment aimed at a specific disease pathway in people with multiple myeloma or acute leukemia. It may help shrink or control cancer cells by targeting how they respond to low-oxygen conditions.
WolverhamptonAges 18 years+ - NCT04231565Recruiting
Testing antiviral medicines for hepatitis B with normal liver blood tests
This trial studies how well nucleoside (nucleoside-acid) type antiviral medicines control hepatitis B in people whose liver enzyme test (ALT) is currently normal. It may help those with active hepatitis B but no major liver inflammation on recent bloodwork.
Guangzhou, GuangdongAges 18–65 - NCT04233788Recruiting
Brain mass imaging study using MRI to learn what causes it
This study uses MRI scanning to better describe a suspected brain mass and understand what it might be. You may be asked to lie in the scanner for about one hour, if you meet the study’s safety and eligibility rules.
BernAges 18 years+ - NCT04240834RecruitingPhase 4
Low-dose ticagrelor vs aspirin after heart stent placement
This study compares ticagrelor taken at a lower dose versus regular aspirin to help prevent future heart attacks in people who recently had a stent placed after acute coronary syndrome. You may qualify if you’re considered “high risk” for new blockages or clots and can take dual anti-platelet therapy for 12 months.
Beijing, Beijing MunicipalityAges 18 years+ - NCT04250493Recruiting
Testing insulin resistance in multiple system atrophy
This study looks at how the body handles blood sugar (insulin resistance) in people with multiple system atrophy (MSA). Results may help doctors understand the disease better and explore new ways to monitor or treat it.
BordeauxAges 30 years+ - NCT04254419RecruitingPhase 1
Natural killer cell injections in the brain tumor area
This early-phase trial tests injections of lab-grown immune cells directly into (or near) a brain tumor. It aims to see if the treatment is safe and can help control recurrent, progressive, or resistant CNS tumors.
Columbus, OhioAges 1–39 - NCT04255563Recruiting
Drug-coated balloon for coronary artery disease
This trial studies a balloon treatment coated with medicine (to help keep the artery open) for people with coronary artery disease. You may be a candidate if you are planned to receive this type of procedure and do not have certain key safety risks.
Nanjing, JiangsuAges 18 years+ - NCT04257994Recruiting
Study how heart cell connections differ in inherited rhythm problems
This study looks at how proteins that connect heart cells are distributed in people with inherited heart rhythm disorders (and some family members who may carry the gene). It aims to better understand the biology behind these conditions, which may help improve risk assessment and future care.
LondonAges 18 years+ - NCT04263922RecruitingPhase 4
Huaiqihuang granules for kidney inflammation in CKD stage 3
This trial studies whether Huaiqihuang granules can improve primary glomerulonephritis (a kidney inflammation) in people with chronic kidney disease at stage 3. It may help control kidney-related measures and reduce progression, compared with standard care.
Beijing, Beijing MunicipalityAges 18–65 - NCT04265703Recruiting
Ultrasound-guided line placement for hard-to-access veins
This study tests a specific ultrasound-guided technique to place a central venous catheter (a medical access line) when jugular veins are difficult to access. It may help reduce failed attempts and improve safety in people who need this kind of line for medical care.
GuadalajaraAges 18–80 - NCT04263935Recruiting
Lymphoma gene changes and what they mean for outcomes
This study looks at lymphoma’s DNA “driver gene” changes and how they relate to symptoms, lab findings, and prognosis (how the disease is expected to do over time). It may help doctors better predict outcomes for people with lymphoma based on their tumor biology.
Zhengzhou, HenanAges Any age - NCT04265040Recruiting
Heart muscle disease registry for non-ischemic conditions
This trial is a registry, meaning it collects health information to help doctors study heart muscle diseases and plan future cardiovascular studies. You may be able to join if you have a non-ischemic cardiomyopathy such as dilated cardiomyopathy, certain forms of thick heart muscle, non-compaction, or arrhythmogenic right-sided disease.
Heidelberg, Baden-WurttembergAges 18–80 - NCT04265144Recruiting
Study group of adults with scleroderma for ongoing care research
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
BordeauxAges 18 years+ - NCT04265599Recruiting
Study of high calcium after oil injections
This study looks at why some people develop high blood calcium after receiving an oil injection into a muscle. It may help researchers understand the cause and find better ways to treat it.
CopenhagenAges 18 years+ - NCT04266977Recruiting
Low-dose steroid timing for newly diagnosed brain tumor surgery
This trial looks at using dexamethasone (a steroid medicine) in a more restricted way for people newly diagnosed with likely glioblastoma who are planned for brain surgery. The goal is to see whether limiting steroid use can still control symptoms while reducing steroid exposure.
Sankt Gallen, St.GallenAges 18–90 - NCT04267978RecruitingPhase 2
Test drug combination for recurrent brain tumor growth
This Phase 2 study tests whether adding recombinant human endostatin to temozolomide and irinotecan can slow or control recurrent gliomas (brain tumors) after prior standard treatment. It may help by targeting tumor blood vessel growth while also using chemotherapy to attack cancer cells.
BeijingAges 18–70 - NCT04270578Recruiting
Study of gestational diabetes during pregnancy and after birth
This trial looks at gestational diabetes (high blood sugar during pregnancy) and may study how it’s managed during pregnancy and postpartum. It may help researchers understand what approaches are safe and useful for people with this condition.
TübingenAges 18 years+ - NCT04271527Recruiting
Compare two prostate biopsy guidance methods in men with PSA rise
This trial tests whether using a “cognitive” approach versus a software-guided approach to plan a prostate biopsy is just as effective. It may help improve how biopsies are targeted for men with PSA changes and/or abnormal prostate exams.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT04271033Recruiting
MicroNet-covered stent to prevent stroke in carotid procedures
This study tests a special stent (a small mesh tube) that may help prevent stroke during a carotid revascularization procedure. It’s for people with narrowing in the carotid artery, either recently symptomatic or very high-grade even without symptoms.
Krakow, MaloplskaAges 18 years+ - NCT04272658Recruiting
Whole-body PET/CT scan during immunotherapy for melanoma
This trial studies how a whole-body PET/CT scan (using a radioactive sugar called FDG) can better track metastatic melanoma in people receiving immune therapy. It may help doctors understand tumor response to medications like nivolumab or pembrolizumab.
Brest, FinistereAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.